187 related articles for article (PubMed ID: 33823169)
41. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of 167 healthy sibling donors after peripheral blood stem cell mobilization with G-CSF 16μg/kg/day: efficacy and safety.
Krejci M; Janikova A; Folber F; Kral Z; Mayer J
Neoplasma; 2015; 62(5):787-92. PubMed ID: 26278142
[TBL] [Abstract][Full Text] [Related]
43. Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests.
Li Y; Chang Y; Xu L; Zhang X; Huang X
Chin Med J (Engl); 2014; 127(20):3597-601. PubMed ID: 25316236
[TBL] [Abstract][Full Text] [Related]
44. Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation.
Schmidt AH; Mengling T; Hernández-Frederick CJ; Rall G; Pingel J; Schetelig J; Ehninger G
Biol Blood Marrow Transplant; 2017 Jun; 23(6):1011-1020. PubMed ID: 28254417
[TBL] [Abstract][Full Text] [Related]
45. [Peripheral monocyte counts at first collection of allo-grafts predicts amount of CD34(+) cells in mixture of rhG-CSF primed bone marrow and mobilized peripheral stem cell grafts].
Chang YJ; Zhao XY; Huo MR; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):146-50. PubMed ID: 19236767
[TBL] [Abstract][Full Text] [Related]
46. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
[TBL] [Abstract][Full Text] [Related]
47. Collection of two peripheral blood stem cell concentrates from healthy donors.
Stroncek DF; Clay ME; Jaszcz W; Lennon S; Smith J; McCullough J
Transfus Med; 1999 Mar; 9(1):37-50. PubMed ID: 10216904
[TBL] [Abstract][Full Text] [Related]
48. Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors.
Behfar M; Faghihi-Kashani S; Hosseini AS; Ghavamzadeh A; Hamidieh AA
Biol Blood Marrow Transplant; 2018 Apr; 24(4):866-870. PubMed ID: 29284143
[TBL] [Abstract][Full Text] [Related]
49. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors.
Rinaldi C; Savignano C; Pasca S; Sperotto A; Patriarca F; Isola M; Fanin R; De Angelis V
Transfusion; 2012 Nov; 52(11):2387-94. PubMed ID: 22452363
[TBL] [Abstract][Full Text] [Related]
51. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
52. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM; Miller JP; Drexler RJ; Abdel-Mageed A; Ahmed IA; Akard LP; Artz AS; Ball ED; Bayer RL; Bigelow C; Bolwell BJ; Broun ER; Delgado DC; Duckworth K; Dvorak CC; Hahn TE; Haight AE; Hari PN; Hayes-Lattin BM; Jacobsohn DA; Jakubowski AA; Kasow KA; Lazarus HM; Liesveld JL; Linenberger M; Litzow MR; Longo W; Magalhaes-Silverman M; McCarty JM; McGuirk JP; Mori S; Parameswaran V; Prasad VK; Rowley SD; Rybka WB; Sahdev I; Schriber JR; Selby GB; Shaughnessy PJ; Shenoy S; Spitzer T; Tse WT; Uberti JP; Vusirikala M; Waller EK; Weisdorf DJ; Yanik GA; Navarro WH; Horowitz MM; Switzer GE; Confer DL; Shaw BE
Haematologica; 2019 Apr; 104(4):844-854. PubMed ID: 30381298
[TBL] [Abstract][Full Text] [Related]
53. The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Prokopishyn NL; Logan BR; Kiefer DM; Sees JA; Chitphakdithai P; Ahmed IA; Anderlini PN; Beitinjaneh AM; Bredeson C; Cerny J; Chhabra S; Daly A; Diaz MA; Farhadfar N; Frangoul HA; Ganguly S; Gastineau DA; Gergis U; Hale GA; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Murthy HS; Norkin M; Olsson RF; Papari M; Savani BN; Szer J; Waller EK; Wirk B; Yared JA; Pulsipher MA; Shah NN; Switzer GE; O'Donnell PV; Confer DL; Shaw BE
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1325-1330. PubMed ID: 30716454
[TBL] [Abstract][Full Text] [Related]
54. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau IW; Basara N; Hölig K; Beelen DW; Hägglund H; Basu O; Ehninger G; Fauser AA
Blood; 1999 Jul; 94(2):455-64. PubMed ID: 10397713
[TBL] [Abstract][Full Text] [Related]
55. Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors.
Fürst D; Hauber D; Reinhardt P; Schauwecker P; Bunjes D; Schulz A; Mytilineos J; Wiesneth M; Schrezenmeier H; Körper S
Vox Sang; 2019 Apr; 114(3):275-282. PubMed ID: 30873634
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
Siddiq S; Pamphilon D; Brunskill S; Doree C; Hyde C; Stanworth S
Cochrane Database Syst Rev; 2009 Jan; (1):CD006406. PubMed ID: 19160282
[TBL] [Abstract][Full Text] [Related]
57. Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors.
Kim-Wanner SZ; Lee SY; Seifried E; Bonig H
J Transl Med; 2020 Dec; 18(1):487. PubMed ID: 33339515
[TBL] [Abstract][Full Text] [Related]
58. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.
Morton J; Hutchins C; Durrant S
Blood; 2001 Dec; 98(12):3186-91. PubMed ID: 11719353
[TBL] [Abstract][Full Text] [Related]
59. Shorter donor leukocyte telomere length is associated with poor peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor.
Yang SH; Liu HT; Wang TF; Liou YS; Sun DS; Wang JH; Chen LY
J Formos Med Assoc; 2024 Jun; ():. PubMed ID: 38914514
[TBL] [Abstract][Full Text] [Related]
60. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
